| 1) Core items |
| Test code |
Test name |
Clinical description |
| C404 |
25-Hydroxyvitamin D (25 OH Vitamin D) |
Assessment of vitamin D deficiency and calcium absorption |
| C547 |
Bone alkaline phosphatase [S] |
Bone formation marker; assessment of bone formation activity |
| S641 |
C-terminal telopeptides (CTX) |
Bone resorption marker; assessment of the degree of bone loss |
| E412 |
Intact parathyroid hormone (PTH) |
Evaluation of parathyroid function (assessment of secondary osteoporosis) |
| K662 |
Osteocalcin |
Reference marker for predicting treatment response reflecting osteoblast activity |
| 2) Optional items |
| Test code |
Test name |
Clinical description |
| S735 |
Deoxypyridinoline (DPD) |
Urine-based bone resorption marker reflecting osteoclast activity |
| E427 |
Estradiol (E2) |
Differential diagnosis of secondary osteoporosis due to sex hormone deficiency |
| Z003 |
N-terminal telopeptide (NTx) |
Assessment of the degree of bone resorption |
| L959 |
Testosterone |
Differential diagnosis of secondary osteoporosis due to sex hormone deficiency |
| N935 |
Total procollagen-type 1 N-terminal propeptide (total P1NP) |
Bone formation marker used for estimation of fracture risk |
| 3) Supplementary items |
| Test code |
Test name |
Clinical description |
| C104 |
Alkaline Phosphatase (ALP) |
Reference marker in the presence of abnormal liver function in addition to bone metabolism |
| C154 |
Calcium, Total [S] |
Assessment of calcium levels related to bone metabolism |
| C448 |
Magnesium (Mg) [S] |
Adjunct marker for bone metabolism |
| C158 |
Phosphorus (Inorganic) |
Assessment of inorganic phosphorus levels related to bone metabolism and renal function |
